Heavy metals and diminished ovarian reserve: single-exposure and mixture analyses amongst women consulting in French fertility centres.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
09 2023
Historique:
received: 09 01 2023
revised: 25 04 2023
accepted: 31 05 2023
medline: 8 9 2023
pubmed: 15 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

Do heavy metals affect the risk of diminished ovarian reserve (DOR) in women of reproductive age? A total of 139 cases and 153 controls were included between 2016 and 2020. The participants were aged between 18 and 40 years and attended consultations for couple infertility in one of four fertility centres in western France. Cases of DOR were defined as women with an antral follicle count less than 7, anti-Müllerian hormone levels 1.1 ng/ml or less, or both. Controls were frequency matched on age groups and centres, and were women with normal ovarian reserve evaluations, no malformations and menstrual cycles between 26 and 35 days. Heavy metals (lead, mercury, cadmium and chromium) were measured in whole blood at inclusion. Single-exposure associations were examined with multivariable logistic regressions adjusted on potential confounders. Mixture effects were investigated with quantile g-computation and Bayesian kernel machine regression (BKMR). Chromium as a continuous exposure was significantly associated with DOR in unadjusted models (OR 2.07, 95% CI 1.04 to 4.13) but the association was no longer significant when confounders were controlled for (adjusted OR 2.75, 95% CI 0.88 to 8.60). Similarly, a statistically significant association was observed for the unadjusted second tercile of cadmium exposure (OR 1.87, 95% CI 1.06 to 3.30); however, this association was no longer statistically significant after adjustment. None of the other associations tested were statistically significant. Quantile g-computation and BKMR both yielded no significant change of risk of DOR for the mixture of metals, with no evidence of interaction. Weak signals that some heavy metals could be associated with DOR were detected. These findings should be replicated in other studies.

Identifiants

pubmed: 37451971
pii: S1472-6483(23)00340-1
doi: 10.1016/j.rbmo.2023.05.013
pii:
doi:

Substances chimiques

Cadmium 00BH33GNGH
Metals, Heavy 0
Chromium 0R0008Q3JB
Anti-Mullerian Hormone 80497-65-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103241

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Maximilien Génard-Walton (M)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France. Electronic address: maximilien.genard-walton@inserm.fr.

Charline Warembourg (C)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Solène Duros (S)

Reproductive Medicine, CHU Rennes, 35200 Rennes, France.

Martine Ropert-Bouchet (M)

Laboratoire de Biochimie Toxicologie, CHU Rennes, Univ Rennes, 35033 Rennes, France.

Tiphaine Lefebvre (T)

Reproductive Medicine, CHU Nantes, 44093 Nantes, France.

Anne Guivarc'h-Levêque (A)

Reproductive Medicine, Clinique de La Sagesse, 35043 Rennes, France.

Marie-Thérèse Le Martelot (MT)

Reproductive Medicine, CHU Brest, 29609 Brest, France.

Bénédicte Jacquemin (B)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Sylvaine Cordier (S)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Nathalie Costet (N)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Luc Multigner (L)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Ronan Garlantézec (R)

Université de Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH